We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+0.01%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
104.12%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
1,571
New
1,571
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.59M |
| 2 |
FirstEnergy
FE
|
+$1.2M |
| 3 |
Eaton
ETN
|
+$1.08M |
| 4 |
Consolidated Edison
ED
|
+$1.06M |
| 5 |
Verizon
VZ
|
+$1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.64% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 13.88% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Healthcare | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Scholar Rock
SRRK
$6.07B
| $1.3K | ﹤0.01% |
+30
| New | +$977 |
|
1502
Cardiff Oncology
CRDF
$65.1M
| $1.26K | ﹤0.01% |
+290
| New | +$906 |
|
1503
First Community Bankshares
FCBC
$843M
| $1.25K | ﹤0.01% |
+30
| New | +$1.32K |
|
1504
Atlas Lithium Corp
ATLX
$83.2M
| $1.2K | ﹤0.01% |
+190
| New | +$1.45K |
|
1505
Dakota Gold
DC
$557M
| $1.19K | ﹤0.01% |
+540
| New | +$1.22K |
|
1506
Alpha Teknova
TKNO
$284M
| $1.17K | ﹤0.01% |
+140
| New | +$975 |
|
1507
Pitney Bowes
PBI
$2.51B
| $1.16K | ﹤0.01% |
+160
| New | +$1.19K |
|
1508
Janux Therapeutics
JANX
$979M
| $1.07K | ﹤0.01% |
+20
| New | +$1.06K |
|
1509
Surgery Partners
SGRY
$2.1B
| $1.06K | ﹤0.01% |
+50
| New | +$1.31K |
|
1510
Rambus
RMBS
$10.9B
| $1.06K | ﹤0.01% |
+20
| New | +$1.02K |
|
|
CADE
1511
DELISTED
Cadence Bank
CADE
| $1.03K | ﹤0.01% |
+30
| New | +$1.05K |
|
1512
The RMR Group
RMR
$340M
| $1.03K | ﹤0.01% |
+50
| New | +$1.16K |
|
1513
Telephone and Data Systems
TDS
$3.85B
| $1.02K | ﹤0.01% |
+30
| New | +$913 |
|
1514
Fate Therapeutics
FATE
$325M
| $990 | ﹤0.01% |
+600
| New | +$1.51K |
|
1515
Atossa Therapeutics
ATOS
$24.8M
| $963 | ﹤0.01% |
+68
| New | +$1.33K |
|
1516
FerroAtlántica
GSM
$620M
| $950 | ﹤0.01% |
+250
| New | +$1.07K |
|
1517
Woori Financial
WF
$15.1B
| $938 | ﹤0.01% |
+30
| New | +$1.03K |
|
|
KALV
1518
DELISTED
KalVista Pharmaceuticals
KALV
| $932 | ﹤0.01% |
+110
| New | +$1.14K |
|
1519
Kyverna Therapeutics
KYTX
$440M
| $898 | ﹤0.01% |
+240
| New | +$1.15K |
|
1520
Cabaletta Bio
CABA
$448M
| $863 | ﹤0.01% |
+380
| New | +$1.33K |
|
1521
Nuvation Bio
NUVB
$2.18B
| $798 | ﹤0.01% |
+300
| New | +$772 |
|
|
EU
1522
enCore Energy
EU
$229M
| $750 | ﹤0.01% |
+220
| New | +$828 |
|
1523
BioAtla
BCAB
$6.14M
| $733 | ﹤0.01% |
+25
| New | +$2.1K |
|
|
AIOT
1524
PowerFleet Inc
AIOT
$580M
| $733 | ﹤0.01% |
+110
| New | +$660 |
|
|
CRGX
1525
DELISTED
CARGO Therapeutics
CRGX
| $721 | ﹤0.01% |
+50
| New | +$907 |
|
Similar funds
NED
CFG
CFG
WCM
OWA
TFP
AFS
EMB
R Squared's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for R Squared, which disclosed 1,571 positions worth $103M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Linde: 5,681 shares worth $2.38M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Technology and Industrials.
- R Squared's largest Q4 2024 buy was Linde: 5,681 shares worth $2.38M.
- R Squared's ten largest holdings make up 11% of its $103M portfolio in Q4 2024.
- R Squared disclosed 1,571 positions in Q4 2024, its first 13F filing on record.
Based on R Squared's 13F filing for Q4 2024, filed 23 Jan 2025.